Click HERE to read a brief news account from the Patently-O blog confirms that the Federal Circuit will rehear the Therasense case en banc. Presumably, the court will tighten the doctrine of inequitable conduct, making it harder to plead and prove that a patent prosecutor intended to deceive the US Patent and Trademark Office.
more